Niagen Bioscience, Inc. Capital Reinvestment Ratio
Niagen Bioscience, Inc. capital reinvestment ratio. Niagen Bioscience, Inc. (NAGE) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow ($2.77 Million) in capital expenditures ($89.00K). Check total reinvestment intensity of Niagen Bioscience, Inc. to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Niagen Bioscience, Inc. (2023–2025)
Capital reinvestment ratio of Niagen Bioscience, Inc. from 2023 to 2025. This chart tracks Niagen Bioscience, Inc.'s Capital Reinvestment Ratio across 3 annual periods. Also explore NAGE net asset momentum to track the company's year-over-year net asset growth rate.
Niagen Bioscience, Inc. Capital Reinvestment Ratio by Year (2023–2025)
Niagen Bioscience, Inc. capital reinvestment ratio by year from 2023 to 2025. For the full cash flow conversion analysis, see NAGE cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $13.44 Million | $292.00K | ▲ +61.4% |
| 2024 | 0.01x | $12.11 Million | $163.00K | ▼ -35.3% |
| 2023 | 0.02x | $7.12 Million | $148.00K | — |